Evidence map›Paper›PMID 41692961›Full record

ReviewThe British journal of radiology2026

From struggle to strength: transforming breast cancer screening for women in low- and middle-income countries.

Dina H Salama, Bibb Allen, Guy Frija, Andrea Rockall, Boris Biljacic, Miriam Mikhail, Youssef Nassef, Christopher Charles Konrad Marton, Diana Paez

Abstract readReview
In one paragraph

Review in The British journal of radiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Dina H SalamaRadiology and Medical Imaging Technology Department, Misr University for Science and Technology, Giza Governorate 3237101, Egypt.ORCID 0000-0003-4736-6723
Bibb AllenPresident, International Society of Radiology, Reston, VA 20191, United States.ORCID 0000-0003-0761-290X
Guy FrijaDepartment of Radiology (Service d'Imagerie Médicale), Paris Cité University, Paris 75006, France.ORCID 0000-0003-0415-0586
Andrea RockallDepartment of Surgery and Cancer, Faculty of Medicine, Imperial College London, London, W2 1NY, United Kingdom.ORCID 0000-0001-8270-5597
Boris BiljacicDepartment of Radiology, School of Medicine, University of Zagreb, Zagreb 10000, Croatia.
Miriam MikhailNuclear Medicine and Diagnostic Imaging Section, Division of Human Health, International Atomic Energy Agency, Vienna A-1400, Austria.ORCID 0000-0002-7402-6014
Youssef NassefFaculty of Medicine, Misr University for Science and Technology, Giza 12566, Egypt.ORCID 0009-0005-1340-7824
Christopher Charles Konrad MartonDivision of Human Health, International Atomic Energy Agency, Vienna A-1400, Austria.
Diana PaezNuclear Medicine and Diagnostic Imaging Section, Division of Human Health, International Atomic Energy Agency, Vienna A-1400, Austria.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Breast cancer is not just a disease; it is a global crisis that continues to claim lives, especially in low- and middle-income countries (LMICs), where late-stage diagnosis is the norm rather than the exception. Unlike high-income countries (HICs), where early detection has significantly improved survival rates, women in LMICs face an uphill battle against fragmented healthcare systems, limited diagnostic tools, cultural barriers, and financial constraints. The very technologies that revolutionized screening in HICs remain out of reach for many, leaving millions vulnerable to preventable deaths. This article calls for bold leadership and coordinated global efforts to ensure that every woman, regardless of geography or socio-economic status, has access to life-saving early detection and treatment, in addition to highlighting the urgent need for equitable breast cancer screening in LMICs and exploring innovative approaches that have the potential to transform early detection and improve outcomes. Decentralized diagnostic hubs, artificial intelligence (AI)-powered imaging, mobile screening units, and public-private partnerships are emerging as viable solutions to bridge the gap. Moreover, creative financing models and culturally tailored awareness campaigns offer hope for overcoming financial and social barriers. We can drive a paradigm shift towards equity in cancer care by reimagining breast cancer screening through technology and community engagement.

Indexed as

Breast NeoplasmsDeveloping CountriesEarly Detection of CancerMass ScreeningFemaleHealth Services AccessibilityHumansMammographyResource-Limited SettingsAI technologiesbreast cancerglobal healthmedical imagingpoliciesscreening

Identifiers

PMID41692961
PMCPMC13070639

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.